News blog

CustomVis

  • BY: Andrew Hore |
  • POSTED: 11/05/2009 |

Moorfields Eye Hospital is trialling the Pulzar Z1 laser developed by CustomVis.

Shares in CustomVis jumped 0.25p to 1.4p a share, which values the laser eye surgery technology developer at 2.37m.

The Moorfields trials should commence in June 2009.

Three Pulzar Z1 lasers have been installed in recent months - two in Saudi Arabia and one in Pakistan - taking the total installed to 40 lasers.

Tracey Technologies Inc will be the exclusive distributor of the iTrace device in Australia and New Zealand. The iTrace is used to measure quality of vision and visual function.

Stuart Usher has been appointed as finance director. 

© 2018 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

News Blog
All micro news

Quoted Micro 22 January 2018

AIM Journal has reached its century, and this edition includes PCF, Sumo and the blockchain boom, here.

Continue reading... | 22/01/2018

IXICO

Neuroscience-focused digital data analysis technology developer IXICO is increasing its revenues and this is cutting the reported loss.

Continue reading... | 22/01/2018

RTC Group

Staffing provider RTC Group says that trading is in line with expectations despite some exposure to Carillion.

Continue reading... | 22/01/2018

Distil

Spirits brands owner Distil says third quarter sales increased by 19%.

Continue reading... | 22/01/2018

All micro news

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds